2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas

NRC Campbell, MP Burnens, PK Whelton… - The Lancet Regional …, 2022 - thelancet.com
Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised
blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult …

[HTML][HTML] World heart federation roadmap for hypertension–A 2021 update

P Jeemon, T Séverin, C Amodeo, D Balabanova… - Global Heart, 2021 - ncbi.nlm.nih.gov
Abstract The World Heart Federation (WHF) Roadmap series covers a large range of
cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions …

[图书][B] Guideline for the pharmacological treatment of hypertension in adults

World Health Organization - 2021 - books.google.com
In this guideline, the World Health Organization (WHO) provides the most current and
relevant evidence-based global public health guidance on the initiation of treatment with …

Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of …

FJ Charchar, PR Prestes, C Mills, SM Ching… - Journal of …, 2024 - journals.lww.com
Hypertension, defined as persistently elevated systolic blood pressure (SBP)> 140 mmHg
and/or diastolic blood pressure (DBP) at least 90 mmHg (International Society of …

The India Hypertension Control Initiative–early outcomes in 26 districts across five states of India, 2018–2020

P Kaur, A Kunwar, M Sharma, K Durgad… - Journal of Human …, 2023 - nature.com
Hypertension is the leading single preventable risk factor for cardiovascular disease. The
India Hypertension Control Initiative (IHCI) project was designed to improve hypertension …

Drivers and scorecards to improve hypertension control in primary care practice: recommendations from the HEARTS in the Americas Innovation Group

JW Brettler, GPG Arcila, T Aumala, A Best… - The Lancet Regional …, 2022 - thelancet.com
Background Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in
the Americas, and hypertension is the most significant modifiable risk factor. However …

HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care

P Ordunez, NRC Campbell… - … de Salud Pública, 2023 - SciELO Public Health
Global Hearts is the flagship initiative of the World Health Organization to reduce the burden
of cardiovascular diseases, the leading cause of death and disability worldwide. HEARTS in …

[HTML][HTML] Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región …

NRC Campbell, M Paccot Burnens… - … de Salud Pública, 2023 - SciELO Public Health
Las enfermedades cardiovasculares son la principal causa de muerte en la Región de las
Américas y la hipertensión es la causa de más del 50% de ellas. En la Región, más de una …

Mapping stages, barriers and facilitators to the implementation of HEARTS in the Americas initiative in 12 countries: a qualitative study

GP Giraldo, KT Joseph, SY Angell… - The Journal of …, 2021 - Wiley Online Library
Abstract The World Health Organization (WHO) Global Hearts Initiative offers technical
packages to reduce the burden of cardiovascular diseases through population‐wide and …

Implementation of global hearts hypertension control programs in 32 low-and middle-income countries: JACC international

AE Moran, R Gupta… - Journal of the American …, 2023 - Elsevier
Abstract In 2017, the World Health Organization (WHO) and Resolve to Save Lives
partnered with country governments and other stakeholders to design, test, and scale up the …